Medically Guided Weight Loss in Cottage Grove, WI

GLP-1 (glucagon-like peptide-1) therapy uses prescription medications that mimic a naturally occurring hormone in the body to help regulate appetite, decrease food cravings, improve blood sugar balance, and support sustainable weight loss.

GLP-1 medications slow gastric emptying, help control hunger cues, enhance insulin sensitivity, and reduce overeating. As a result, most patients experience reduced appetite, improved portion control, and steady weight loss when combined with healthy lifestyle habits.

Most patients begin to notice appetite changes in the first few weeks, with gradual weight loss occurring over several months.

GLP-1 therapy duration varies by individual goals. Some patients use it short-term to kick-start weight loss, while others stay on it longer for ongoing metabolic support. Your provider will reassess progress regularly and create a personalized plan.

Some patients experience mild side effects, typically during the dose-adjustment period. Common symptoms may include nausea, bloating, diarrhea, or fatigue. These often improve as the body adjusts. Our team will guide you through supportive measures to minimize discomfort.

Yes—when prescribed and monitored by a licensed medical provider. At Juniper Reign, your therapy plan is overseen by experienced clinicians who monitor labs, dosage, and progress to ensure your safety and success.

GLP-1 medications are not appropriate for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. They should also be avoided by anyone who has experienced a serious allergic reaction to the medication or any of its ingredients. Use during pregnancy or while breastfeeding is not recommended because safety has not been clearly established. These medications may not be suitable for people with severe gastrointestinal conditions, such as gastroparesis, since they slow stomach emptying. In addition, individuals with a history of pancreatitis, or those at elevated risk for it, may not be good candidates depending on the specific medication and clinical judgment.